Related Experiment Video

Updated: Aug 30, 2026

An Ex vivo Model to Study Hormone Action in the Human Breast
12:31

An Ex vivo Model to Study Hormone Action in the Human Breast

Published on: January 8, 2015

The biology of antihormone failure in breast cancer

Robert I Nicholson1, Julia M W Gee, Janice Knowlden

  • 1Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK. nicholsonri@cardiff.ac.uk

Breast Cancer Research and Treatment
|October 11, 2003
PubMed

Insights

Tamoxifen resistance in estrogen receptor-positive breast cancer is a major challenge. Targeting growth factor signaling pathways, like epidermal growth factor receptor (EGFR), may overcome this resistance and improve treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Estrogen receptor-positive breast cancer often develops resistance to tamoxifen, leading to disease relapse.
  • Understanding the mechanisms of tamoxifen resistance is crucial for developing effective treatments.
  • Growth factor signaling pathways interact with estrogen signaling and may drive resistance.

Purpose of the Study:

  • To explore the role of growth factor signaling pathways in tamoxifen resistance.
  • To identify potential therapeutic targets for antihormone-refractory breast cancer.
  • To evaluate the potential of EGFR inhibitors in treating resistant breast cancer.

Main Methods:

  • Review of existing literature on estrogen and growth factor signaling in breast cancer.
  • Analysis of the role of epidermal growth factor receptor (EGFR) signaling in tamoxifen resistance.
  • Discussion of targeted therapies, including EGFR inhibitors like gefitinib.

Main Results:

  • Growth factor signaling pathways, particularly EGFR, are implicated in the development of tamoxifen resistance.
  • Abnormalities in EGFR signaling can promote the growth of antihormonal-resistant breast cancer cells.
  • EGFR inhibitors show promise as a therapeutic strategy for resistant breast cancer.

Conclusions:

  • Targeting growth factor signaling pathways, such as EGFR, is a promising approach to overcome tamoxifen resistance.
  • Inhibitory agents targeting EGFR may provide clinical benefit in antihormone-refractory breast cancer.
  • Therapies targeting growth factor signaling pathways could prevent the development of resistance.

More Related Videos

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

Related Concept Videos

Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Hormonal Regulation02:03

Hormonal Regulation

Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.The ProcessStarting in the stomach, when proteins are detected by sensory neurons of the enteric nervous system, the pyloric gland is stimulated to release gastrin. In turn, this hormone induces the release of histamine. Combined, they...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Chemical Signaling in the Endocrine System01:08

Chemical Signaling in the Endocrine System

A signaling cascade is a series of events that facilitates the transmission of information within or between cells, culminating in a targeted response in the recipient cell. As chemical messengers, hormones are pivotal in initiating and modulating these intricate signaling cascades based on their solubility.
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...